HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soo-A Kim Selected Research

cinnamaldehyde (cinnamic aldehyde)

11/2017Cinnamaldehyde protects human dental pulp cells against oxidative stress through the Nrf2/HO-1-dependent antioxidant response.
1/20172'-Hydroxycinnamaldehyde induces apoptosis through HSF1-mediated BAG3 expression.
11/2015The anticancer mechanism of 2'-hydroxycinnamaldehyde in human head and neck cancer cells.
12/20122'-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soo-A Kim Research Topics

Disease

26Neoplasms (Cancer)
12/2021 - 04/2006
6Mouth Neoplasms (Oral Cancer)
03/2018 - 04/2010
5Carcinogenesis
07/2012 - 09/2004
4Neoplasm Metastasis (Metastasis)
03/2022 - 02/2010
3Wounds and Injuries (Trauma)
03/2018 - 02/2010
3Adenocarcinoma
02/2011 - 03/2010
2Colonic Neoplasms (Colon Cancer)
03/2022 - 01/2017
2Atherosclerosis
01/2017 - 07/2010
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2015 - 07/2011
2Squamous Cell Carcinoma of Head and Neck
10/2012 - 09/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2012 - 09/2004
2Congenital Structural Myopathies (Centronuclear Myopathy)
12/2003 - 02/2002
2Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
12/2003 - 02/2002
1Colorectal Neoplasms (Colorectal Cancer)
03/2022
1Type 2 Diabetes Mellitus (MODY)
03/2018
1Insulin Resistance
01/2018
1Malignant Mesothelioma
08/2017
1Acute Erythroblastic Leukemia (Erythroleukemia)
10/2015
1Skin Neoplasms (Skin Cancer)
01/2014
1Hyperplasia
07/2012
1Carcinoma (Carcinomatosis)
05/2012
1Lung Neoplasms (Lung Cancer)
03/2012
1Infections
01/2012
1Communicable Diseases (Infectious Diseases)
01/2012
1Necrosis
07/2010
1Inflammation (Inflammations)
07/2010
1Calcifying Odontogenic Cyst
03/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2002
1Inborn Genetic Diseases (Disease, Hereditary)
02/2002

Drug/Important Bio-Agent (IBA)

61-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2016 - 11/2009
6indirubinIBA
03/2012 - 01/2007
5Small Interfering RNA (siRNA)IBA
01/2017 - 04/2010
4cinnamaldehyde (cinnamic aldehyde)FDA Link
11/2017 - 12/2012
4AcidsIBA
08/2017 - 07/2010
3Proliferating Cell Nuclear Antigen (PCNA)IBA
03/2018 - 11/2009
3Paclitaxel (Taxol)FDA LinkGeneric
12/2016 - 05/2012
3Proteins (Proteins, Gene)FDA Link
07/2012 - 02/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 07/2010
2pheophorbide aIBA
12/2016 - 01/2014
2Histone Deacetylase InhibitorsIBA
01/2016 - 02/2012
2Messenger RNA (mRNA)IBA
10/2015 - 07/2012
2Photosensitizing Agents (Photosensitizers)IBA
01/2014 - 11/2009
2Biological ProductsIBA
12/2012 - 03/2008
2Toll-Like Receptors (Toll-Like Receptor)IBA
05/2012 - 02/2011
2trichostatin A (A 300)IBA
02/2012 - 06/2007
2theasinensin AIBA
02/2012 - 06/2007
2Integrin beta1IBA
07/2011 - 02/2010
2EstersIBA
09/2010 - 07/2010
2beta CateninIBA
03/2008 - 01/2007
2myotubularinIBA
12/2003 - 02/2002
1quercitrinIBA
03/2022
1QuercetinIBA
03/2022
1MicroRNAs (MicroRNA)IBA
12/2021
1Transcription Factors (Transcription Factor)IBA
12/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2018
1Insulin-Like PeptidesIBA
03/2018
1BiguanidesIBA
03/2018
1HL156AIBA
03/2018
1TOR Serine-Threonine KinasesIBA
03/2018
1Metformin (Glucophage)FDA LinkGeneric
03/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1AntioxidantsIBA
11/2017
1Lactic Acid (Lactate)FDA LinkGeneric
08/2017
1cariporideIBA
08/2017
1Caspase 7IBA
01/2017
1ChlorophyllIBA
01/2014
1TransferasesIBA
07/2012
1Biomarkers (Surrogate Marker)IBA
07/2012
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
07/2012
1Poly I-CIBA
05/2012
1NIMA-Interacting Peptidylprolyl IsomeraseIBA
03/2012
1Polo-Like Kinase 1IBA
03/2012
1Histones (Histone)IBA
02/2012
1ChromatinIBA
02/2012
1IntegrinsIBA
07/2011
1CateninsIBA
02/2011
1FlagellinIBA
02/2011
1Toll-Like Receptor 5IBA
02/2011
1alanylalanine (Ala-Ala)IBA
09/2010
1Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2010
1CytokinesIBA
07/2010
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
06/2010
1Pharmaceutical PreparationsIBA
06/2010
1Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2010
1TeaIBA
06/2010
1matrigelIBA
02/2010
1phytochlorinIBA
11/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2007
1Thrombospondin 1IBA
06/2007
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
09/2004
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2004
1anthraceneIBA
09/2004
1Phosphoinositide PhosphatasesIBA
12/2003
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2002

Therapy/Procedure

9Therapeutics
03/2022 - 04/2006
6Photochemotherapy (Photodynamic Therapy)
12/2016 - 11/2009
1Aftercare (After-Treatment)
07/2011